OMERS Administration Corp’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,100
Closed -$330K 459
2017
Q3
$330K Buy
5,100
+100
+2% +$6.13K ﹤0.01% 377
2017
Q2
$271K Buy
5,000
+100
+2% +$5.33K ﹤0.01% 426
2017
Q1
$273K Buy
+4,900
New +$257K ﹤0.01% 307
2016
Q4
Sell
-6,800
Closed -$408K 500
2016
Q3
$408K Buy
+6,800
New +$365K 0.01% 508
2016
Q2
Sell
-6,000
Closed -$247K 642
2016
Q1
$247K Buy
6,000
+1,000
+20% +$39.1K 0.01% 506
2015
Q4
$341K Buy
+5,000
New +$302K 0.01% 405
2015
Q3
Sell
-12,900
Closed -$679K 467
2015
Q2
$679K Hold
12,900
0.03% 310
2015
Q1
$492K Hold
12,900
0.02% 320
2014
Q4
$268K Sell
12,900
-2,300
-15% -$48K 0.01% 375
2014
Q3
$337K Buy
+15,200
New +$322K 0.01% 318

Other funds holding PRTA

OMERS Administration Corp's PRTA Position: Q4 2017 in Review

OMERS Administration Corp sold out of Prothena Corp (PRTA) in Q4 2017, closing a stake of 5,100 shares — an estimated $330K sold.

OMERS Administration Corp first reported a position in PRTA in Q3 2014 and held it in 10 quarters. The position peaked at $679K in Q2 2015. 155 funds tracked by Wall St. Rank hold PRTA as of Q4 2017.

  • OMERS Administration Corp reported no remaining Prothena Corp position as of Q4 2017 after selling out during the quarter.
  • OMERS Administration Corp sold 5,100 Prothena Corp shares in Q4 2017, an estimated $330K.
  • OMERS Administration Corp first reported a position in Prothena Corp in Q3 2014 and held it in 10 quarters.
  • OMERS Administration Corp's Prothena Corp position peaked at $679K in Q2 2015.
  • 155 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2017.

Based on OMERS Administration Corp's 13F filing for Q4 2017, filed 13 Feb 2018.